1. 3016Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension. (28th August 2018) Authors: Galie, N; Gaine, S; Channick, R; Ghofrani, H A; Hoeper, M; Lang, I; McLaughlin, V; Preiss, R; Rubin, L; Shiraga, Y; Simonneau, G; Sitbon, O; Tapson, V; Chin, K Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Issue 9 (31st August 2005) Authors: Tamby, M C; Chanseaud, Y; Humbert, M; Fermanian, J; Guilpain, P; Garcia-de-la-Peña-Lefebvre, P; Brunet, S; Servettaz, A; Weill, B.; Simonneau, G; Guillevin, L; Boissier, M C; Mouthon, L Journal: Thorax Issue: Volume 60:Issue 9(2005) Page Start: 765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antifibroblast antibodies from systemic sclerosis patients bind to α-enolase and are associated with interstitial lung disease. Issue 2 (16th March 2009) Authors: Terrier, B; Tamby, M C; Camoin, L; Guilpain, P; Bérezné, A; Tamas, N; Broussard, C; Hotellier, F; Humbert, M; Simonneau, G; Guillevin, L; Mouthon, L Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 2(2010) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in cMRI parameters following a switch to riociguat from phosphodiesterase type 5 inhibitors (PDE5i) in patients with pulmonary arterial hypertension: a REPLACE substudy. (14th October 2021) Authors: Rosenkranz, S; Benza, R L; Ghofrani, H A; Gruenig, E; Hoeper, M M; Peacock, A; Simonneau, G; Vizza, D; Meier, C; Vogtlaender, K; Vonk-Noordegraaf, A Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Early neutrophil alveolitis after rechallenge in drug induced alveolitis. Issue 8 (August 1988) Authors: Salmeron, S; Brochard, L; Rain, B; Herve, P; Brenot, F; Simonneau, G; Duroux, P Journal: Thorax Issue: Volume 43:Issue 8(1988) Page Start: 647 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension. Issue 5 (28th April 2004) Authors: Chaouat, A; Coulet, F; Favre, C; Simonneau, G; Weitzenblum, E; Soubrier, F; Humbert, M Journal: Thorax Issue: Volume 59:Issue 5(2004) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Improvement of severe pulmonary hypertension in a patient with SLE. Issue 8 (August 1996) Authors: Karmochkine, M; Wechsler, B; Godeau, P; Brenot, F; Jagot, J L; Simonneau, G Journal: Annals of the rheumatic diseases Issue: Volume 55:Issue 8(1996) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long term imatinib treatment in pulmonary arterial hypertension. Issue 8 (28th July 2006) Authors: Souza, R; Sitbon, O; Parent, F; Simonneau, G; Humbert, M Journal: Thorax Issue: Volume 61:Issue 8(2006) Page Start: 736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study. (25th November 2020) Authors: Galie, N; Sitbon, O; Doelberg, M; Gibbs, J.S.R; Hoeper, M.M; Martin, N; Mathai, S.C; McLaughlin, V; Perchenet, L; Simonneau, G; Chin, K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P149 Effect of macitentan on pulmonary arterial hypertension-related hospitalisations: results from the randomised controlled SERAPHIN trial. (14th November 2013) Authors: Coghlan, G; Channick, RN; Rubin, LJ; Galiè, N; Perchenet, L; Simonneau, G Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗